Failure to Manage G-Tube Care and Medication Monitoring
Summary
The facility failed to ensure a physician assistant appropriately managed the care of a resident who required nutrition and hydration via a gastrostomy tube and who had complications related to tube feedings and medication administration through the g-tube. The resident had moderate cognitive impairment, used a walker, and required assistance with several activities of daily living. Her care plan addressed tube feeding and some general skin and incontinence issues, but it did not identify actual skin breakdown on the coccyx, refusal of cares and treatments, risk for fluid-volume imbalance, specific head-of-bed elevation requirements during and after tube feedings, or symptoms and monitoring related to hypercalcemia, hypothyroidism, and hyperparathyroidism. The resident’s orders included Vital Advanced Formula via g-tube, scheduled water flushes, and multiple medications administered through the g-tube, including levothyroxine, prednisone, iron-vitamin liquid, folic acid, apixaban, metoprolol tartrate, senna, cinacalcet, omeprazole suspension, and ascorbic acid. The physician orders lacked directions for monitoring electrolytes, accurate intake and output, fluid balance related to tube feedings and free water, medication interactions, prevention of adverse effects, ongoing monitoring for nausea, vomiting, and abdominal pain, and when staff should notify the provider if the resident refused medications or treatments. During interviews, the physician assistant stated the resident had a complicated GI tract and hyperparathyroidism causing hypercalcemia, and that symptom management was the primary direction of care because she was no longer a surgical candidate. The physician assistant also stated she did not plan to order follow-up bloodwork because she thought consulting services would monitor electrolytes, was unsure of the electrolyte monitoring schedule, was unsure how involved nutrition services were, and had not directly communicated with the consultant pharmacist about medication timing in relation to tube feedings. Another provider stated facility providers were expected to manage calcium levels after discharge and that medication interactions and administration times should be assessed by the facility provider and pharmacist.
Penalty
Resources
Below are regulatory guidelines relevant to this citation:
Trusted data from CMS and state health departments
Every citation, penalty and Plan of Correction is sourced from public CMS records (latest release August 26, 2026) and official state health department websites — never guesswork.
In your survey window? See what surveyors are citing.
The Survey-Prep Report maps your facility's risk from 12 months of CMS and state citation data — what's being cited around you and what to check first. $129 one-time.